Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$9,469,779
+$321,612 QoQ
Shares Held
37,287
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.29%
of 13F equity value
Holder Rank
#1,144
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. JNJ ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,469,779 | 37,287 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $9,148,167 | 37,425 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $7,852,510 | 37,944 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,076,739 | 38,166 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,840,090 | 38,233 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,432,601 | 38,788 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,636,130 | 38,972 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,432,647 | 39,693 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,921,526 | 40,514 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,309,408 | 39,885 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,144,208 | 39,200 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,046,838 | 38,824 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,407,279 | 38,710 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,001,910 | 38,722 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,843,067 | 38,738 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,393,583 | 39,138 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $6,899,458 | 38,868 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $7,126,772 | 40,212 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $6,859,735 | 40,099 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,341,136 | 39,264 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $6,474,940 | 39,304 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $6,748,704 | 41,063 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $6,418,113 | 40,781 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,245,962 | 41,953 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $6,087,450 | 43,287 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,747,296 | 43,829 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||